FINGOLIMOD Mepha caps 0.5 mg 98 pce
7680680070147
CH-68007
L04AE01
01.99.0.
Reimbursement limitations:
GILENYA3
Traitement de la sclérose en plaques (SEP) récurrente-rémittente chez l’adulte. Première prescription par un neurologue.
1 / 3
google
Details
- Product number
- 6800702
- CPT
- -
- Packaging group
- 98
- Unit
- Kapsel(n)
- Composition
- fingolimodum 0.5 mg ut fingolimodi hydrochloridum, amylum pregelificatum, natrii laurilsulfas corresp. natrium < 23 mg, Kapselhülle: gelatina, E 171, E 172 (flavum), Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, E 172 (nigrum), kalii hydroxidum pro capsula.
Articles (1)
Fingolimod-Mepha 0,5 mg, Kapseln
Kapseln
98
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1464.85
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/05/2022
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 68007
- Drug name
- Fingolimod-Mepha, Kapseln
- Galenic form
- KAPS
- ATC Code
- L04AE01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 11/01/2022
- Authorization expiration date
- 10/01/2027
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FINGOLIMOD Mepha caps 0.5 mg 98 pce
- Description (DE)
- FINGOLIMOD Mepha Kaps 0.5 mg 98 Stk
- Market launch
- 11/01/2022
- Narcotic (BTM)
- No